[브로셔] Accelerated Development, Manufacturing and Monitoring of Viral Vectors 본문 목록 이전글 [어플리케이션 노트] Control and scale-up of a microcarrier-based viral vaccine process using BioPAT ® ViaMass for inline viable cell de 다음글 [브로셔] ABL Europe’s GMP manufacturing facility for viral vector production